Patent · US Active

Pure erlotinib

US9340515B2 · kind B2 · utility

0Cited by

3References

18Claims

0Family size

Assignee

Generics [UK] Limited · GB

Inventors

Vinayak Govind Gore · Panvel, IN
Anilkumar Tripathi · Jamkhed, IN
Madhav Jadhav · Jamkhed, IN

Key dates

Filing date	Jan 6, 2015
Grant date	May 17, 2016
Priority date	—
Expiry date	Jan 6, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to processes for the preparation of erlotinib and salts and polymorphs thereof preparable by said processes, to medical uses of said erlotinib, salts and polymorphs, and to pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.